BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37078383)

  • 1. Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study.
    Zhang M; Morice AH; Si F; Zhang L; Chen Q; Wang S; Zhu Y; Xu X; Yu L; Qiu Z
    Ther Adv Respir Dis; 2023; 17():17534666231167716. PubMed ID: 37078383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flupentixol/melitracen for chronic refractory cough after treatment failure with other neuromodulators.
    Chen Q; Zhang M; Si F; Wang S; Xu X; Yu L; Lai K; Qiu Z
    Int J Tuberc Lung Dis; 2021 Aug; 25(8):648-654. PubMed ID: 34330350
    [No Abstract]   [Full Text] [Related]  

  • 3. New Insights Into Refractory Chronic Cough and Unexplained Chronic Cough: A 6-Year Ambispective Cohort Study.
    Zhang M; Morice AH; Si F; Zhang L; Chen Q; Wang S; Zhu Y; Xu X; Yu L; Qiu Z
    Allergy Asthma Immunol Res; 2023 Nov; 15(6):795-811. PubMed ID: 37957796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and Long-term Effects of Neuromodulators for Unexplained Chronic Cough.
    Bowen AJ; Nowacki AS; Contrera K; Trask D; Kaltenbach J; Milstein CF; Adessa M; Benninger MS; Taliercio R; Bryson PC
    Otolaryngol Head Neck Surg; 2018 Sep; 159(3):508-515. PubMed ID: 29634404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised clinical trial: gabapentin vs baclofen in the treatment of suspected refractory gastro-oesophageal reflux-induced chronic cough.
    Dong R; Xu X; Yu L; Ding H; Pan J; Yu Y; Shi C; Chen Q; Zhang M; Lv H; Qiu Z
    Aliment Pharmacol Ther; 2019 Mar; 49(6):714-722. PubMed ID: 30740748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review.
    Cohen SM; Misono S
    Otolaryngol Head Neck Surg; 2013 Mar; 148(3):374-82. PubMed ID: 23300226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial.
    Ryan NM; Birring SS; Gibson PG
    Lancet; 2012 Nov; 380(9853):1583-9. PubMed ID: 22951084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tachyphylaxis and Dependence in Pharmacotherapy for Unexplained Chronic Cough.
    Bowen AJ; Huang TL; Nowacki AS; Trask D; Kaltenbach J; Taliercio R; Benninger MS; Milstein CF; Bryson PC
    Otolaryngol Head Neck Surg; 2018 Oct; 159(4):705-711. PubMed ID: 30016197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported experiences with refractory or unexplained chronic cough: a qualitative analysis.
    Bali V; Schelfhout J; Sher MR; Tripathi Peters A; Patel GB; Mayorga M; Goss D; Romano CD
    Ther Adv Respir Dis; 2024; 18():17534666241236025. PubMed ID: 38501735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin versus baclofen for treatment of refractory gastroesophageal reflux-induced chronic cough.
    Zhang M; Zhu Y; Dong R; Qiu Z
    J Thorac Dis; 2020 Sep; 12(9):5243-5250. PubMed ID: 33145100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis.
    Domingo C; Fernandez M; Garin N; Milara J; Moran I; Muerza I; Pacheco A; Teruel C; Bentley R; Subiran R; Gil A
    Appl Health Econ Health Policy; 2023 Jan; 21(1):119-130. PubMed ID: 36319945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study.
    Dávila I; Puente L; Quirce S; Arismendi E; Díaz-Palacios M; Pereira-Vega A; de Diego A; Rodriguez-Hermosa JL; Cea-Calvo L; Sánchez-Jareño M; López-Cotarelo P; Domingo C
    Lung; 2023 Jun; 201(3):275-286. PubMed ID: 37160771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Codeine Treatment Responders Among Patients with Refractory or Unexplained Chronic Cough: A Prospective Real-World Cohort Study.
    Oh JY; Kang SY; Kang N; Won HK; Jo EJ; Lee SE; Lee JH; Shim JS; Kim YC; Yoo Y; An J; Lee HY; Park SY; Kim MY; Lee JH; Kim BK; Park HK; Kim MH; Kim SH; Kim SH; Chang YS; Kim SH; Lee BJ; Chung KF; Cho SH; Song WJ;
    Lung; 2024 Apr; 202(2):97-106. PubMed ID: 38411774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speech and language therapy for management of chronic cough.
    Slinger C; Mehdi SB; Milan SJ; Dodd S; Matthews J; Vyas A; Marsden PA
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD013067. PubMed ID: 31335963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough.
    Mazzone SB; McGarvey L
    Clin Pharmacol Ther; 2021 Mar; 109(3):619-636. PubMed ID: 32748976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cough desensitization treatment for patients with refractory chronic cough: results of a second pilot randomized control trial.
    Slovarp LJ; Reynolds JE; Tolbert S; Campbell S; Welby S; Morkrid P
    BMC Pulm Med; 2023 Apr; 23(1):148. PubMed ID: 37118696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Severity of Chronic Cough Diary (SCCD): development and content validation of a novel patient-reported outcome instrument for evaluating the symptom experience of chronic cough.
    de la Orden Abad M; Haberland C; Karn H; Skalicky A; Hareendran A
    J Patient Rep Outcomes; 2023 Jul; 7(1):65. PubMed ID: 37428359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of gabapentin for the treatment of refractory cough associated with interstitial lung disease: study protocol for a randomized, double-blind and placebo-controlled clinical trial.
    Gao R; Xu X; Wang S; Pu J; Shi C; Wen S; Zhu Y; Tang J; Wang X; Yu L
    Trials; 2022 Feb; 23(1):165. PubMed ID: 35189953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the clinical development of gefapixant, a P2X3 receptor antagonist for the treatment of refractory chronic cough.
    Muccino D; Green S
    Pulm Pharmacol Ther; 2019 Jun; 56():75-78. PubMed ID: 30880151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.